<?xml version="1.0" encoding="UTF-8"?>
<p>Clinical studies have recommended a dose of 500 mg of chloroquine twice per day for 10 days, in patients with mild, moderate or severe COVID-19 pneumonia, when there were no contraindications to the drug. In adults 600 mg of chloroquine can be given and then 300 mg after 12 h on day 1. Afterwards, 300 mg/2 days on days 2–5 days and finishing the treatment at day 5 to decrease the risk of side effects, the drug has a long half-life (30 h) [
 <xref rid="B52-medicina-56-00386" ref-type="bibr">52</xref>]. Chloroquine was efficient against SARS-CoV-2 in Vero E6 cells using a 50% and 90% effective concentration (EC50 and EC90 values) of 1.13 μM and 6.90 μM. Therefore, chloroquine improves the evolution of pneumonia in COVID-19 patients [
 <xref rid="B53-medicina-56-00386" ref-type="bibr">53</xref>].
</p>
